Location of cAMP-dependent protein kinase type I with the TCR-CD3 complex.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 8272870.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Selective activation of cyclic adenosine 3',5'-monophosphate (cAMP)-dependent protein kinase type I (cAKI), but not type II, is sufficient to mediate inhibition of T cell replication induced through the antigen-specific T cell receptor-CD3 (TCR-CD3) complex. Immunocytochemistry and immunoprecipitation studies of the molecular mechanism by which cAKI inhibits TCR-CD3-dependent T cell replication demonstrated that regulatory subunit I alpha, along with its associated kinase activity, translocated to and interacted with the TCR-CD3 complex during T cell activation and capping. Regulatory subunit II alpha did not. When stimulated by cAMP, the cAKI localized to the TCR-CD3 complex may release kinase activity that, through phosphorylation, might uncouple the TCR-CD3 complex from intracellular signaling systems.
Medical subject headings
- Carrier Proteins
- Cyclic AMP-Dependent Protein Kinases
- Intracellular Signaling Peptides and Proteins
- Receptor-CD3 Complex, Antigen, T-Cell
- T-Lymphocytes